Abstract
Recent advance in adipocyte biology revealed that adipose tissue is a secretory organ. Such fat-derived secretory factors are now called adipocytokines, conceptually. Adipocytokines known to date include leptin, TNF-α, resistin, PAI-1, and adiponectin. Physiological production and secretion of adipocytokines maintains metabolic and vascular homeostasis, by functioning to adipocyte itself through auto- and para-crine fashions, and remote organ through blood stream. Dysregulated production of adipocytokines, too much or too little, in obesity and lipodystrophy, lead to the development of metabolic syndrome including insulin resistant diabetes and vascular disease. Restoring the plasma levels of adipocytkines have been shown to reverse such metabolic syndrome associated with obesity and lipodystrophy. Adipocytokines are now becoming a central target to tackle the metabolic syndrome.
Keywords: adipocytokine, leptin, plasminogen activator inhibitor, tumor necrosis factor, resistin, adiponectin, metabolic syndrome, visceral fat, adipo-vascular axis, lipodystrophy
Current Medicinal Chemistry - Central Nervous System Agents
Title: Adipocytokines; Cause for Metabolic Syndrome
Volume: 3 Issue: 2
Author(s): Iichiro Shimomura, Tohru Funahashi and Yuji Matsuzawa
Affiliation:
Keywords: adipocytokine, leptin, plasminogen activator inhibitor, tumor necrosis factor, resistin, adiponectin, metabolic syndrome, visceral fat, adipo-vascular axis, lipodystrophy
Abstract: Recent advance in adipocyte biology revealed that adipose tissue is a secretory organ. Such fat-derived secretory factors are now called adipocytokines, conceptually. Adipocytokines known to date include leptin, TNF-α, resistin, PAI-1, and adiponectin. Physiological production and secretion of adipocytokines maintains metabolic and vascular homeostasis, by functioning to adipocyte itself through auto- and para-crine fashions, and remote organ through blood stream. Dysregulated production of adipocytokines, too much or too little, in obesity and lipodystrophy, lead to the development of metabolic syndrome including insulin resistant diabetes and vascular disease. Restoring the plasma levels of adipocytkines have been shown to reverse such metabolic syndrome associated with obesity and lipodystrophy. Adipocytokines are now becoming a central target to tackle the metabolic syndrome.
Export Options
About this article
Cite this article as:
Shimomura Iichiro, Funahashi Tohru and Matsuzawa Yuji, Adipocytokines; Cause for Metabolic Syndrome, Current Medicinal Chemistry - Central Nervous System Agents 2003; 3 (2) . https://dx.doi.org/10.2174/1568015033477848
DOI https://dx.doi.org/10.2174/1568015033477848 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
Related Articles
-
The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Systemic Administration of Fluoro-Gold for the Histological Assessment of Vascular Structure, Integrity and Damage
Current Neurovascular Research Diabetes of the Brain: Computational Approaches and Interventional Strategies
CNS & Neurological Disorders - Drug Targets Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry Time Dependent Distribution of MicroRNA 144 after Intravenous Delivery
MicroRNA Glycogen Phosphoprylase (EC 2.4.1.1) Activity During Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery
Vascular Disease Prevention (Discontinued) Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Antioxidant Properties of Nitric Oxide in Cellular Physiological and Pathophysiological Mechanisms. The Implications of Biological Balance between NO and Oxidative Stress
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Biomarker Discovery and Translation in Metabolomics
Current Metabolomics Protection by Natural Honey Against Hyperhomocysteinemia in Rats
Vascular Disease Prevention (Discontinued) L-Arginine in the Prevention and Treatment of Cardiovascular Disease: From Basic to Clinical Research Studies
Vascular Disease Prevention (Discontinued) Physical Activity, Insulin Action, and Diabetes Prevention and Control
Current Diabetes Reviews Mood Stabilizers, Oxidative Stress and Antioxidative Defense in Euthymia of Bipolar Disorder
CNS & Neurological Disorders - Drug Targets Evaluation of Nutritional Constituent and Fatty Acid Profiles of Different Tropical Fruit Residues
Current Nutrition & Food Science Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
Current Medicinal Chemistry Antipsoriatic Drug Development: Challenges and New Emerging Therapies
Recent Patents on Inflammation & Allergy Drug Discovery CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?
Current Signal Transduction Therapy Hypertension and Concurrent Arrhythmias
Current Pharmaceutical Design